{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:13:19Z","timestamp":1791411199750,"version":"4.3.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T00:00:00Z","timestamp":1442966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T00:00:00Z","timestamp":1442966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Insulin-degrading enzyme (IDE) is a protease that cleaves insulin and other bioactive peptides such as amyloid-\u03b2. Knockout and genetic studies have linked IDE to Alzheimer\u2019s disease and type-2 diabetes. As the major insulin-degrading protease, IDE is a candidate drug target in diabetes. Here we have used kinetic target-guided synthesis to design the first catalytic site inhibitor of IDE suitable for <jats:italic>in vivo<\/jats:italic> studies (BDM44768). Crystallographic and small angle X-ray scattering analyses show that it locks IDE in a closed conformation. Among a panel of metalloproteases, BDM44768 selectively inhibits IDE. Acute treatment of mice with BDM44768 increases insulin signalling and surprisingly impairs glucose tolerance in an IDE-dependent manner. These results confirm that IDE is involved in pathways that modulate short-term glucose homeostasis, but casts doubt on the general usefulness of the inhibition of IDE catalytic activity to treat diabetes.<\/jats:p>","DOI":"10.1038\/ncomms9250","type":"journal-article","created":{"date-parts":[[2015,9,23]],"date-time":"2015-09-23T11:19:58Z","timestamp":1443007198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice"],"prefix":"10.1038","volume":"6","author":[{"given":"Rebecca","family":"Deprez-Poulain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Hennuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Bosc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguang G.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"En\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Marechal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Charton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Totobenazara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzague","family":"Berte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouda","family":"Jahklal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Verdelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Dassonneville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Woitrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Gauriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Duplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Hermant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois- Xavier","family":"Cantrelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Sevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Culot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Landry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Herledan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Piveteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Lippens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Endert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Deprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,23]]},"reference":[{"key":"BFncomms9250_CR1","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.2174\/138161209789271799","volume":"15","author":"A Fernandez-Gamba","year":"2009","unstructured":"Fernandez-Gamba, A., Leal, M. C., Morelli, L. & Castano, E. M. Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease. Curr. Pharm. Des. 15, 3644\u20133655 (2009) .","journal-title":"Curr. Pharm. Des."},{"key":"BFncomms9250_CR2","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1007\/s00018-006-6238-9","volume":"63","author":"LB Hersh","year":"2006","unstructured":"Hersh, L. B. The insulysin (insulin degrading enzyme) enigma. Cell. Mol. Life Sci. 63, 2432\u20132434 (2006) .","journal-title":"Cell. Mol. Life Sci."},{"key":"BFncomms9250_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0014-5793(94)00387-4","volume":"345","author":"IV Kurochkin","year":"1994","unstructured":"Kurochkin, I. V. & Goto, S. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345, 33\u201337 (1994) .","journal-title":"FEBS Lett."},{"key":"BFncomms9250_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jmb.2009.10.072","volume":"395","author":"Q Guo","year":"2010","unstructured":"Guo, Q., Manolopoulou, M., Bian, Y., Schilling, A. B. & Tang, W.-J. Molecular basis for the recognition and cleavages of IGF-II, TGF-[alpha], and amylin by human insulin-degrading enzyme. J. Mol. Biol. 395, 430\u2013443 (2010) .","journal-title":"J. Mol. Biol."},{"key":"BFncomms9250_CR5","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1210\/en.2003-0543","volume":"144","author":"F Authier","year":"2003","unstructured":"Authier, F., Cameron, P. H., Merlen, C., Kouach, M. & Briand, G. Endosomal proteolysis of glucagon at neutral pH generates the bioactive degradation product miniglucagon-(19-29). Endocrinology 144, 5353\u20135364 (2003) .","journal-title":"Endocrinology"},{"key":"BFncomms9250_CR6","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.2337\/diabetes.52.9.2315","volume":"52","author":"RG Bennett","year":"2003","unstructured":"Bennett, R. G., Hamel, F. G. & Duckworth, W. C. An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures. Diabetes 52, 2315\u20132320 (2003) .","journal-title":"Diabetes"},{"key":"BFncomms9250_CR7","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.jmb.2008.11.025","volume":"385","author":"C Ciaccio","year":"2009","unstructured":"Ciaccio, C. et al. Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity. J. Mol. Biol. 385, 1556\u20131567 (2009) .","journal-title":"J. Mol. Biol."},{"key":"BFncomms9250_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0014-5793(98)00422-0","volume":"427","author":"IV Kurochkin","year":"1998","unstructured":"Kurochkin, I. V. Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme. FEBS Lett. 427, 153\u2013156 (1998) .","journal-title":"FEBS Lett."},{"key":"BFncomms9250_CR9","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nature05143","volume":"443","author":"Y Shen","year":"2006","unstructured":"Shen, Y., Joachimiak, A., Rosner, M. R. & Tang, W. J. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 443, 870\u2013874 (2006) .","journal-title":"Nature"},{"key":"BFncomms9250_CR10","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1007\/s00018-008-8112-4","volume":"65","author":"E Malito","year":"2008","unstructured":"Malito, E., Hulse, R. & Tang, W. J. Amyloid \u03b2-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin. Cell. Mol. Life Sci. 65, 2574\u20132585 (2008) .","journal-title":"Cell. Mol. Life Sci."},{"key":"BFncomms9250_CR11","doi-asserted-by":"publisher","first-page":"22711","DOI":"10.1074\/jbc.C110.217893","volume":"286","author":"K Glebov","year":"2011","unstructured":"Glebov, K., Sch\u00fctze, S. & Walter, J. Functional relevance of a novel SlyX motif in non-conventional secretion of insulin-degrading enzyme. J. Biol. Chem. 286, 22711\u201322715 (2011) .","journal-title":"J. Biol. Chem."},{"key":"BFncomms9250_CR12","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1677\/joe.0.1770399","volume":"177","author":"RG Bennett","year":"2003","unstructured":"Bennett, R. G., Fawcett, J., Kruer, M. C., Duckworth, W. C. & Hamel, F. G. Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme. J. Endocrinol. 177, 399\u2013405 (2003) .","journal-title":"J. Endocrinol."},{"key":"BFncomms9250_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/jcp.21500","volume":"217","author":"CL Epting","year":"2008","unstructured":"Epting, C. L. et al. Stem cell antigen-1 localizes to lipid microdomains and associates with insulin degrading enzyme in skeletal myoblasts. J. Cell. Physiol. 217, 250\u2013260 (2008) .","journal-title":"J. Cell. Physiol."},{"key":"BFncomms9250_CR14","doi-asserted-by":"publisher","first-page":"e67705","DOI":"10.1371\/journal.pone.0067705","volume":"8","author":"C Beuzelin","year":"2013","unstructured":"Beuzelin, C. et al. Deletion of the fission yeast homologue of human insulinase reveals a TORC1-dependent pathway mediating resistance to proteotoxic stress. PLoS ONE 8, e67705 (2013) .","journal-title":"PLoS ONE"},{"key":"BFncomms9250_CR15","doi-asserted-by":"publisher","first-page":"e59113","DOI":"10.1371\/journal.pone.0059113","volume":"8","author":"MB de Tullio","year":"2013","unstructured":"de Tullio, M. B. et al. Proteolytically inactive insulin-degrading enzyme inhibits amyloid formation yielding non-neurotoxic Ab peptide aggregates. PLoS ONE 8, e59113 (2013) .","journal-title":"PLoS ONE"},{"key":"BFncomms9250_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1126\/science.122.3169.559","volume":"122","author":"IA Mirsky","year":"1955","unstructured":"Mirsky, I. A. & Perisutti, G. Effect of insulinase-inhibitor on hypoglycemic action of insulin. Science 122, 559\u2013560 (1955) .","journal-title":"Science"},{"key":"BFncomms9250_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng0196-31","volume":"12","author":"J Galli","year":"1996","unstructured":"Galli, J. et al. Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nat. Genet. 12, 31\u201337 (1996) .","journal-title":"Nat. Genet."},{"key":"BFncomms9250_CR18","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1093\/hmg\/9.14.2149","volume":"9","author":"H Fakhrai-Rad","year":"2000","unstructured":"Fakhrai-Rad, H. et al. Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats. Hum. Mol. Genet. 9, 2149\u20132158 (2000) .","journal-title":"Hum. Mol. Genet."},{"key":"BFncomms9250_CR19","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1016\/S0002-9440(10)63229-4","volume":"164","author":"W Farris","year":"2004","unstructured":"Farris, W. et al. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am. J. Pathol. 164, 1425\u20131434 (2004) .","journal-title":"Am. J. Pathol."},{"key":"BFncomms9250_CR20","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1073\/pnas.0230450100","volume":"100","author":"W Farris","year":"2003","unstructured":"Farris, W. et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl Acad. Sci. USA 100, 4162\u20134167 (2003) .","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms9250_CR21","doi-asserted-by":"publisher","first-page":"e20818","DOI":"10.1371\/journal.pone.0020818","volume":"6","author":"SO Abdul-Hay","year":"2012","unstructured":"Abdul-Hay, S. O. et al. Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance. PLoS ONE 6, e20818 (2012) .","journal-title":"PLoS ONE"},{"key":"BFncomms9250_CR22","doi-asserted-by":"publisher","first-page":"e10504","DOI":"10.1371\/journal.pone.0010504","volume":"5","author":"MA Leissring","year":"2010","unstructured":"Leissring, M. A. et al. Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS ONE 5, e10504 (2010) .","journal-title":"PLoS ONE"},{"key":"BFncomms9250_CR23","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1021\/jm301280p","volume":"56","author":"SO Abdul-Hay","year":"2013","unstructured":"Abdul-Hay, S. O. et al. Optimization of peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivity. J. Med. Chem. 56, 2246\u20132255 (2013) .","journal-title":"J. Med. Chem."},{"key":"BFncomms9250_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature13297","volume":"511","author":"JP Maianti","year":"2014","unstructured":"Maianti, J. P. et al. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones. Nature 511, 94\u201398 (2014) .","journal-title":"Nature"},{"key":"BFncomms9250_CR25","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1039\/b904092g","volume":"39","author":"X Hu","year":"2010","unstructured":"Hu, X. & Manetsch, R. Kinetic target-guided synthesis. Chem. Soc. Rev. 39, 1316\u20131324 (2010) .","journal-title":"Chem. Soc. Rev."},{"key":"BFncomms9250_CR26","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/1521-3773(20020315)41:6<1053::AID-ANIE1053>3.0.CO;2-4","volume":"41","author":"WG Lewis","year":"2002","unstructured":"Lewis, W. G. et al. Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks. Angew. Chem. Int. Ed. Engl. 41, 1053\u20131057 (2002) .","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"BFncomms9250_CR27","doi-asserted-by":"publisher","first-page":"12809","DOI":"10.1021\/ja046382g","volume":"126","author":"R Manetsch","year":"2004","unstructured":"Manetsch, R. et al. In situ click chemistry: enzyme inhibitors made to their own specifications. J. Am. Chem. Soc. 126, 12809\u201312818 (2004) .","journal-title":"J. Am. Chem. Soc."},{"key":"BFncomms9250_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/anie.200461580","volume":"44","author":"VP Mocharla","year":"2005","unstructured":"Mocharla, V. P. et al. In situ click chemistry: enzyme-generated inhibitors of carbonic anhydrase II. Angew. Chem. Int. Ed. Engl. 44, 116 (2005) .","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"BFncomms9250_CR29","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/anie.200502161","volume":"45","author":"M Whiting","year":"2006","unstructured":"Whiting, M. et al. Inhibitors of HIV-1 protease by using in situ click chemistry. Angew. Chem. Int. Ed. Engl. 45, 1435\u20131439 (2006) .","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"BFncomms9250_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/ja.2009.28","volume":"62","author":"T Hirose","year":"2009","unstructured":"Hirose, T. et al. Chitinase inhibitors: extraction of the active framework from natural argifin and use of in situ click chemistry. J. Antibiot. 62, 277 (2009) .","journal-title":"J. Antibiot."},{"key":"BFncomms9250_CR31","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1021\/cb100177g","volume":"5","author":"N Willand","year":"2010","unstructured":"Willand, N. et al. Exploring drug target flexibility using in situ click chemistry: application to a mycobacterial transcriptional regulator. ACS Chem. Biol. 5, 1007\u20131013 (2010) .","journal-title":"ACS Chem. Biol."},{"key":"BFncomms9250_CR32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejmech.2014.04.009","volume":"79","author":"J Charton","year":"2014","unstructured":"Charton, J. et al. Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-b hydrolysis. Eur. J. Med. Chem. 79, 184\u2013193 (2014) .","journal-title":"Eur. J. Med. Chem."},{"key":"BFncomms9250_CR33","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1002\/chem.200204678","volume":"9","author":"JK Lau","year":"2003","unstructured":"Lau, J. K. et al. Absolute potassium cation affinities (PCAs) in the gas phase. Chemistry 9, 3383 (2003) .","journal-title":"Chemistry"},{"key":"BFncomms9250_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/BF00528774","volume":"10","author":"RD Brown","year":"1968","unstructured":"Brown, R. D., Coller, B. A. W. & Kent, J. E. 1,2,5-, 1,3,4- and 1,2,4-oxadiazoles: a theoretical study of electric dipole moments. Theor. Chim. Acta 10, 435\u2013446 (1968) .","journal-title":"Theor. Chim. Acta"},{"key":"BFncomms9250_CR35","doi-asserted-by":"publisher","first-page":"13827","DOI":"10.1073\/pnas.1304575110","volume":"110","author":"LA McCord","year":"2013","unstructured":"McCord, L. A. et al. Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme. Proc. Natl Acad. Sci. USA 110, 13827\u201313832 (2013) .","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms9250_CR36","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.1021\/jm900648x","volume":"52","author":"M Flipo","year":"2009","unstructured":"Flipo, M. et al. Hydroxamates: relationships between structure and plasma stability. J. Med. Chem. 52, 6790\u20136802 (2009) .","journal-title":"J. Med. Chem."},{"key":"BFncomms9250_CR37","doi-asserted-by":"publisher","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"WQ Qiu","year":"1998","unstructured":"Qiu, W. Q. et al. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem. 273, 32730\u201332738 (1998) .","journal-title":"J. Biol. Chem."},{"key":"BFncomms9250_CR38","doi-asserted-by":"publisher","first-page":"13389","DOI":"10.1074\/jbc.M111571200","volume":"277","author":"D Edbauer","year":"2002","unstructured":"Edbauer, D., Willem, M., Lammich, S., Steiner, H. & Haass, C. Insulin-degrading enzyme rapidly removes the b-amyloid precursor protein intracellular domain (AICD). J. Biol. Chem. 277, 13389\u201313393 (2002) .","journal-title":"J. Biol. Chem."},{"key":"BFncomms9250_CR39","doi-asserted-by":"publisher","first-page":"14177","DOI":"10.1074\/jbc.M900068200","volume":"284","author":"M Manolopoulou","year":"2009","unstructured":"Manolopoulou, M., Guo, Q., Malito, E., Schilling, A. B. & Tang, W. J. Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme. J. Biol. Chem. 284, 14177\u201314188 (2009) .","journal-title":"J. Biol. Chem."},{"key":"BFncomms9250_CR40","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","volume":"276","author":"Z Otwinowski","year":"1997","unstructured":"Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307\u2013326 (1997) .","journal-title":"Methods Enzymol."},{"key":"BFncomms9250_CR41","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1107\/S0907444902015391","volume":"58","author":"E Potterton","year":"2002","unstructured":"Potterton, E., McNicholas, S., Krissinel, E., Cowtan, K. & Noble, M. The CCP4 molecular-graphics project. Acta Crystallogr. D Biol. Crystallogr. 58, 1955\u20131957 (2002) .","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFncomms9250_CR42","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004) .","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"BFncomms9250_CR43","first-page":"213","volume":"D 66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213\u2013221 (2010) .","journal-title":"Acta Crystallogr."},{"key":"BFncomms9250_CR44","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1107\/S0021889892001663","volume":"25","author":"D Svergun","year":"1992","unstructured":"Svergun, D. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Cryst. 25, 495\u2013503 (1992) .","journal-title":"J. Appl. Cryst."},{"key":"BFncomms9250_CR45","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1107\/S0021889895007047","volume":"28","author":"D Svergun","year":"1995","unstructured":"Svergun, D., Barbareto, C. & Koch, G. CRYSOL- a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates. J. Appl. Cryst. 28, 768\u2013773 (1995) .","journal-title":"J. Appl. Cryst."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms9250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms9250","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms9250.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T10:53:28Z","timestamp":1672916008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms9250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,11,24]]}},"alternative-id":["BFncomms9250"],"URL":"https:\/\/doi.org\/10.1038\/ncomms9250","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,23]]},"assertion":[{"value":"9 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8250"}}